nsc 664704 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, YM | 1 |
| Gupta, SK | 1 |
| Kim, KJ | 1 |
| Powers, BE | 1 |
| Cerqueira, A | 1 |
| Wainger, BJ | 1 |
| Ngo, HD | 1 |
| Rosowski, KA | 1 |
| Schein, PA | 1 |
| Ackeifi, CA | 1 |
| Arvanites, AC | 1 |
| Davidow, LS | 1 |
| Woolf, CJ | 1 |
| Rubin, LL | 1 |
1 other study available for nsc 664704 and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzazepines; Cell Differentiation; Cell Survival; Cells, Cu | 2013 |